Therapeutic Efficacy and Safety of Botulinum Toxin Type A in Erythematotelangiectatic Rosacea: A Systematic Review
Cureus · 11.04.2026
DOI: 10.7759/cureus.106841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 11.04.2026. Verfasst von Khadija Marrar und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Almarefa University, Riyadh, SAU. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, Almarefa University, Riyadh, SAU.
- College of Health Science and Rehabilitation, Princess Nourah University, Riyadh, SAU.
- College of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busiteen, BHR.
- Department of Dermatology, King Saud Medical City, Riyadh, SAU.
- College of Medicine, Umm-Al Qura University, Makkah, SAU.
- College of Medicine, King Abdulaziz University, Jeddah, SAU.
Zitieren
APA
Marrar, K., Althiyabi, R., Alsannaa, M., Alfalah, R., Soroje, J., Anbar, E., Al Ibrahim, I., & Al Awadhi, A. (2026). Therapeutic Efficacy and Safety of Botulinum Toxin Type A in Erythematotelangiectatic Rosacea: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.106841
Vancouver
Marrar K, Althiyabi R, Alsannaa M, Alfalah R, Soroje J, Anbar E, et al. Therapeutic Efficacy and Safety of Botulinum Toxin Type A in Erythematotelangiectatic Rosacea: A Systematic Review. Cureus. 2026. doi:10.7759/cureus.106841
BibTeX
@article{Marrar2026,
author = {Marrar, Khadija and Althiyabi, Rawan and Alsannaa, Maria and Alfalah, Renad and Soroje, Jumanah and Anbar, Eyad and Al Ibrahim, Ibtiahl and Al Awadhi, Ameen},
title = {Therapeutic Efficacy and Safety of Botulinum Toxin Type A in Erythematotelangiectatic Rosacea: A Systematic Review},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106841}
}
EUVIMED